Literature DB >> 8645849

Massive hepatic steatosis and lactic acidosis in a patient with AIDS who was receiving zidovudine.

J P Olano1, M J Borucki, J W Wen, A K Haque.   

Abstract

Massive steatosis has recently been described among a few human immunodeficiency virus-seropositive patients who were receiving antiretroviral therapy. Although clinical and light-microscopic pathological findings were carefully described, no ultrastructural studies of the liver were performed in these cases. We report the light-microscopic and ultrastructural findings at autopsy of a 35-year-old woman with AIDS who developed severe lactic acidosis and hepatic failure. The patient had been receiving standard doses of zidovudine for 5 months when she was hospitalized because of the rapid onset of abdominal pain, nausea, and vomiting. The most significant findings at autopsy were massive hepatomegaly and steatosis. Ultrastructural examination of the liver and skeletal muscle showed slightly enlarged mitochondria in the liver but no mitochondrial changes in the skeletal muscle. The pathogenesis of mitochondrial toxicity associated with antiviral therapies is briefly discussed.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8645849     DOI: 10.1093/clinids/21.4.973

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  15 in total

1.  Zidovudine inhibits thymidine phosphorylation in the isolated perfused rat heart.

Authors:  Delia Susan-Resiga; Alice T Bentley; Matthew D Lynx; Darcy D LaClair; Edward E McKee
Journal:  Antimicrob Agents Chemother       Date:  2007-01-12       Impact factor: 5.191

2.  3'-Azido-3'-deoxythymidine (AZT) is a competitive inhibitor of thymidine phosphorylation in isolated rat heart and liver mitochondria.

Authors:  Matthew D Lynx; Edward E McKee
Journal:  Biochem Pharmacol       Date:  2006-04-25       Impact factor: 5.858

3.  Differential effects of antiretroviral nucleoside analogs on mitochondrial function in HepG2 cells.

Authors:  X R Pan-Zhou; L Cui; X J Zhou; J P Sommadossi; V M Darley-Usmar
Journal:  Antimicrob Agents Chemother       Date:  2000-03       Impact factor: 5.191

4.  Acute hepatic failure and lactate acidosis associated with antiretroviral treatment for HIV.

Authors:  Robert O Koch; Ivo W Graziadei; Robert Zangerle; Nikolaus Romani; Hans Maier; Wolfgang Vogel
Journal:  Wien Klin Wochenschr       Date:  2003-02-28       Impact factor: 1.704

Review 5.  Aging and HIV/AIDS: pathogenetic role of therapeutic side effects.

Authors:  Rebecca A Torres; William Lewis
Journal:  Lab Invest       Date:  2013-12-16       Impact factor: 5.662

Review 6.  Toxicity of antiretroviral nucleoside and nucleotide analogues: is mitochondrial toxicity the only mechanism?

Authors:  G Moyle
Journal:  Drug Saf       Date:  2000-12       Impact factor: 5.606

Review 7.  Adverse effects of antiretroviral therapy for HIV infection.

Authors:  Valentina Montessori; Natasha Press; Marianne Harris; Linda Akagi; Julio S G Montaner
Journal:  CMAJ       Date:  2004-01-20       Impact factor: 8.262

8.  PharmGKB summary: zidovudine pathway.

Authors:  Yogita Ghodke; Peter L Anderson; Katrin Sangkuhl; Jatinder Lamba; Russ B Altman; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2012-12       Impact factor: 2.089

9.  [Nucleoside induced hepatopathy in HIV patients. Diagnostic value of liver biopsy assessment].

Authors:  S Haas; J K Rockstroh; U Spengler; H-P Fischer
Journal:  Pathologe       Date:  2004-09       Impact factor: 1.011

10.  3'-Azido-3'-deoxythymidine (AZT) inhibits thymidine phosphorylation in isolated rat liver mitochondria: a possible mechanism of AZT hepatotoxicity.

Authors:  Matthew D Lynx; Alice T Bentley; Edward E McKee
Journal:  Biochem Pharmacol       Date:  2006-02-10       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.